59089-68-8 Usage
Description
2',4'-Difluoro-4-hydroxy biphenyl, also known as Diflunisal EP Impurity B, is an organic compound characterized by the presence of two fluorine atoms at the 2' and 4' positions of a biphenyl molecule, along with a hydroxyl group at the 4-position. 2',4'-DIFLUORO-4-HYDROXY BIPHENYL is known for its potential applications in the pharmaceutical industry due to its unique structural features and properties.
Uses
Used in Pharmaceutical Industry:
2',4'-Difluoro-4-hydroxy biphenyl is used as an intermediate in the synthesis of Diflunisal (D445752), which is an analgesic and anti-inflammatory drug. Its role in the synthesis process is crucial for the development of effective pain relief and inflammation management medications.
As an intermediate, 2',4'-Difluoro-4-hydroxy biphenyl contributes to the production of Diflunisal by undergoing a series of chemical reactions that ultimately result in the formation of the desired analgesic and anti-inflammatory compound. This makes it an essential component in the pharmaceutical industry for the development and manufacturing of pain relief and inflammation management drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 59089-68-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,9,0,8 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 59089-68:
(7*5)+(6*9)+(5*0)+(4*8)+(3*9)+(2*6)+(1*8)=168
168 % 10 = 8
So 59089-68-8 is a valid CAS Registry Number.
59089-68-8Relevant articles and documents
Aniline analogs as glycogen synthase activators
-
Page/Page column 14, (2011/05/13)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid
-
, (2008/06/13)
A process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid comprising the reaction of an organometallic derivative with a suitable substituted benzene in the presence of a transition-metal based catalyst is described.
Process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid
-
, (2008/06/13)
A process for the preparation of 5-(2,4-difluorophenyl)-salicylic acid comprising the reaction of an organometallic derivative with a suitable substituted benzene in the presence of a transition-metal based catalyst is described.